ATE131873T1 - Cytokine - Google Patents

Cytokine

Info

Publication number
ATE131873T1
ATE131873T1 AT90810481T AT90810481T ATE131873T1 AT E131873 T1 ATE131873 T1 AT E131873T1 AT 90810481 T AT90810481 T AT 90810481T AT 90810481 T AT90810481 T AT 90810481T AT E131873 T1 ATE131873 T1 AT E131873T1
Authority
AT
Austria
Prior art keywords
derivatives
polypeptides
mediators
hybrid vectors
dnas
Prior art date
Application number
AT90810481T
Other languages
English (en)
Inventor
Karel Gerrit Odink
Lajos Tarcsay
Josef Brueggen
Walter Wiesendanger
Nico Cerletti
Clemens Sorg
Christiane Dewolf-Peeters
Jan Delabie
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Application granted granted Critical
Publication of ATE131873T1 publication Critical patent/ATE131873T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3061Blood cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Control Of Transmission Device (AREA)
  • Control Of Driving Devices And Active Controlling Of Vehicle (AREA)
  • Radar Systems Or Details Thereof (AREA)
AT90810481T 1989-07-05 1990-06-26 Cytokine ATE131873T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898915414A GB8915414D0 (en) 1989-07-05 1989-07-05 Novel cytokines

Publications (1)

Publication Number Publication Date
ATE131873T1 true ATE131873T1 (de) 1996-01-15

Family

ID=10659582

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90810481T ATE131873T1 (de) 1989-07-05 1990-06-26 Cytokine

Country Status (14)

Country Link
US (2) US5411882A (de)
EP (1) EP0412050B1 (de)
JP (1) JPH0356499A (de)
AT (1) ATE131873T1 (de)
AU (1) AU649226B2 (de)
CA (1) CA2020303A1 (de)
DD (1) DD298948A5 (de)
DE (1) DE69024279T2 (de)
DK (1) DK0412050T3 (de)
ES (1) ES2081960T3 (de)
GB (1) GB8915414D0 (de)
GR (1) GR3018521T3 (de)
IE (1) IE70519B1 (de)
PT (1) PT94575B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2052602T3 (es) * 1986-10-03 1994-07-16 Ciba Geigy Ag Nuevos peptidos afines a las linfocinas.
ATE311895T1 (de) 1992-05-26 2005-12-15 Immunex Corp Neue zytokine die cd30 binden
US6645493B1 (en) * 1993-05-17 2003-11-11 The Picower Institute For Medical Research Composition containing anti-MIF antibody
US6774227B1 (en) * 1993-05-17 2004-08-10 Cytokine Pharmasciences, Inc. Therapeutic uses of factors which inhibit or neutralize MIF activity
UY27304A1 (es) 2001-05-24 2002-12-31 Avanir Pharmaceuticals Inhibidores del factor inhibidor de la migración de los macrófagos y métodos para su identificación
TW200418829A (en) 2003-02-14 2004-10-01 Avanir Pharmaceutics Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
CN1839133A (zh) * 2003-08-22 2006-09-27 阿文尼尔药品公司 作为巨噬细胞移动抑制因子的抑制剂的取代的二氮杂萘衍生物及其在治疗人类疾病中的应用
WO2006068398A1 (en) 2004-12-20 2006-06-29 Isu Abxis Co., Ltd. Molecules inhibition intercellular adhesion
US7740856B2 (en) * 2005-12-20 2010-06-22 Isu Abxis Co., Ltd. Effect of BST2 on inflammation
US8329186B2 (en) * 2004-12-20 2012-12-11 Isu Abxis Co., Ltd Treatment of inflammation using BST2 inhibitor
US20080299128A1 (en) * 2006-06-20 2008-12-04 Myung Kim Effect of Bst2 on inflammation
WO2006102191A1 (en) * 2005-03-24 2006-09-28 Avanir Pharmaceuticals Thienopyridinone derivatives as macrophage migration inhibitory factor inhibitors
MXPA05011139A (es) * 2005-10-17 2007-04-17 Concretos Translucidos S De R Formulacion para obtener una mezcla de concreto conductivo.
GB0605689D0 (en) * 2006-03-21 2006-05-03 Novartis Ag Organic compounds
US9249217B2 (en) * 2010-12-03 2016-02-02 Secretary, DHHS Bispecific EGFRvIII x CD3 antibody engaging molecules
US9958456B2 (en) 2011-10-07 2018-05-01 Baxalta Incorporated OxMIF as a diagnostic marker

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0672158B2 (ja) * 1984-05-24 1994-09-14 チバ−ガイギ− アクチエンゲゼルシヤフト 精製されたヒトマクロファージ遊走阻止因子
US5008374A (en) * 1986-03-14 1991-04-16 Otsuka Pharmaceutical Co., Ltd. IL-1α derivatives and drugs
ES2052602T3 (es) * 1986-10-03 1994-07-16 Ciba Geigy Ag Nuevos peptidos afines a las linfocinas.
ATE149176T1 (de) * 1987-10-02 1997-03-15 Univ Rockefeller Von makrophagen abstammender entzündungsvermittler(mip-1-alpha et mip-1-beta)

Also Published As

Publication number Publication date
JPH0356499A (ja) 1991-03-12
AU5809590A (en) 1991-01-10
PT94575B (pt) 1997-02-28
EP0412050A1 (de) 1991-02-06
IE70519B1 (en) 1996-12-11
IE902426A1 (en) 1991-06-19
ES2081960T3 (es) 1996-03-16
DE69024279T2 (de) 1996-10-17
DD298948A5 (de) 1992-03-19
AU649226B2 (en) 1994-05-19
GB8915414D0 (en) 1989-08-23
GR3018521T3 (en) 1996-03-31
DE69024279D1 (de) 1996-02-01
PT94575A (pt) 1991-03-20
EP0412050B1 (de) 1995-12-20
US5411882A (en) 1995-05-02
US5821336A (en) 1998-10-13
DK0412050T3 (da) 1996-01-29
CA2020303A1 (en) 1991-01-06

Similar Documents

Publication Publication Date Title
ATE131873T1 (de) Cytokine
WO1990010709A3 (en) Monoclonal antibodies for metallic cations on small molecules
DE69630710D1 (de) Humaner tumornekrosefaktor delta und epsilon
ATE131872T1 (de) Latenz assoziierte peptide und deren verwendung
DE69721548D1 (de) HUMANE ANTIKÖRPER WELCHE AN HUMANEN TNFalpha BINDEN
CY1109093T1 (el) Πρωτεϊνες των υποδοχεων θηλαστικων, σχετικα αντιδραστηρια και σχετικες μεθοδοι
ATE183241T1 (de) Impstoff gegen streptococcus suis-infektion
FI873410A0 (fi) Kahden uuden hybridooman tuottamia apolipoproteiini-B-spesifisiä monoklonaalisia vasta-aineita
KR900701318A (ko) 항-사람 고분자량- 흑색종 관련 항원에 대한 항-이디오 타입 항체
DE69504959D1 (de) Humanisierte monoklonale antikörper gegen humanes interleukin - 4
DK592086A (da) Humant conglutinin
ES8800052A1 (es) Un procedimiento para preparar una proteina de superficie antigenica de anaplasma marginale
DE3570677D1 (en) Acino-foetal differentiation proteins associated with cancer of the pancreas, antiserum and monoclonal antibodies against these proteins and processes for their preparation
DE3579808D1 (de) Anti-urokinase monoklonaler antikoerper, seine herstellung und verwendung.
WO2000017363A3 (en) Interleukin-1 like molecule: interleukin-1-zeta; nucleic acids, polypeptides, antibodies, their uses
WO1999019480A3 (en) Human receptor proteins; related reagents and methods
ITTO911003A0 (it) Metodo rapido per l'identificazione dello s.aureus, kit diagnostico per l'esecuzione di tale metodo, anticorpi monoclonali contro la glucosaminidasi dello s. aureus e ibridoma per la produzione di tali anticorpi.
DK182188A (da) Humant tumorassocieret antigen
GR890100333A (en) Antihuman antigen antibodies
BG48881A1 (en) Hybridomic cell line mus musculus h 5/9, secretizing monoclonal antibodies against rickettsia conorii
ATE124722T1 (de) Für das plazentaprotein 9 (pp9) kodierende cdna, ihre isolierung und verwendung.
WO2001046419A3 (en) Mammalian prion proteins; related reagents and methods

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee